Is City Therapeutics Inc. overvalued?

City Therapeutics Inc. (CTY) — key valuation metrics and fundamentals.

No verdict

Price

$18.10

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$176.0M

Dividend yield

0.0%

Return on equity

18.3%

Sector

Healthcare

Fair value compares CTY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks